To ensure we are providing accurate and timely information, we only list articles on studies that are published in peer-reviewed periodicals and provide information to help you live well with PD. ​ CLICK FOR A FULL LIST OF ARTICLES AND RESEARCH STUDIES

Early-stage trial for Parkinson’s disease therapy shows signs of promise
(Initial results from phase 1 open label study)

While double-blind studies are critical to assure efficacy, a phase 1 open study shows positive results from the use of Bendaneprocel therapy to replace dopamine producing cells for those with Parkinson’s Disease.
“The data from this phase 1 open label study are extremely encouraging,” said Claire Henchcliffe, a neurologist at the University of California, Irvine, who was one of the study’s principal investigators. “While this is a small open label study, meeting the study’s primary objective for safety and tolerability along with initial improvements seen in clinical outcomes represents a great step forward. The hope now is that these trends continue and translate into meaningful benefit for people with Parkinson’s disease in controlled clinical trials.”  Read more​
CLICK TO READ THE FULL ARTICLE

PUBLISHED RESEARCH

 To ensure we are providing accurate and timely information, we only list articles on studies that are published in peer-reviewed periodicals and provide information to help you live well with PD.  To find additional papers and research CLICK HERE